+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cancer Pain Management Market by Drug Type, Route of Administration, Application, End-Use - Global Forecast 2025-2030- Product Image
Cancer Pain Management Market by Drug Type, Route of Administration, Application, End-Use - Global Forecast 2025-2030- Product Image
Sale

Cancer Pain Management Market by Drug Type, Route of Administration, Application, End-Use - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5924846
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cancer Pain Management Market grew from USD 7.42 billion in 2023 to USD 7.86 billion in 2024. It is expected to continue growing at a CAGR of 6.09%, reaching USD 11.23 billion by 2030.

The cancer pain management market encompasses a comprehensive range of solutions aimed at alleviating pain associated with cancer, including pharmacological treatments, non-pharmacological therapies, and advanced medical devices. The necessity of effective pain management arises from the debilitating nature of cancer-related pain, which can significantly impact patients' quality of life. Applications range from managing acute and chronic cancer pain to improving palliative care, with end-use spanning hospitals, ambulatory surgical centers, and home care settings. Key growth factors include an increasing prevalence of cancer, advancing healthcare infrastructure, and heightened awareness of pain management options. Additionally, the development of novel analgesics and the integration of digital pain management platforms present potential opportunities for market expansion. Recommendations to capture these opportunities include investing in R&D for targeted therapies and embracing technology like AI for personalized pain management. However, the market faces challenges such as regulatory hurdles, potential opioid misuse, and pricing pressures, which can impede growth. Encouraging diversification into complementary therapies such as acupuncture and promoting non-opioid treatment alternatives could mitigate these challenges. Innovation can further drive growth through the development of biodegradable drug delivery systems and the exploration of cannabinoid-based therapies, which are gaining acceptance. Market dynamics are influenced by the rapid evolution of treatment protocols and the complex reimbursement landscape. Overall, businesses should focus on the integration of multi-modal pain management approaches that personalize treatment while ensuring accessibility to broader patient demographics. Emphasizing strategic alliances with healthcare providers and continuous engagement with regulatory bodies can also provide competitive advantages. In essence, the cancer pain management market presents a fertile ground for innovation and collaboration, promising extensive growth opportunities for those adept at navigating its intricacies and challenges.

Understanding Market Dynamics in the Cancer Pain Management Market

The Cancer Pain Management Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising prevalence of chronic pain and lifestyle disorders worldwide
    • Increasing geriatric population and need for pain-reducing therapies
  • Market Restraints
    • Issues associated with product recalls
  • Market Opportunities
    • Ongoing product development activities and rising FDA approvals of new products
    • Government funding supporting cancer pain treatments
  • Market Challenges
    • Adverse effects associated with cancer pain management drugs

Exploring Porter’s Five Forces for the Cancer Pain Management Market

Porter’s Five Forces framework further strengthens the insights of the Cancer Pain Management Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Cancer Pain Management Market

External macro-environmental factors deeply influence the performance of the Cancer Pain Management Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Cancer Pain Management Market

The Cancer Pain Management Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Cancer Pain Management Market

The Cancer Pain Management Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Cancer Pain Management Market

The Cancer Pain Management Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cancer Pain Management Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., Aegis Therapeutics, LLC, Aptinyx Inc., Astellas Pharma Inc., Bausch Health Companies Inc., Baxter International Inc., Bayer AG, Biogen Inc., Boehringer Ingelheim International GmbH, Eisai Co., Ltd., Eli Lilly and Company, Glaxosmithkline PLC, Grünenthal Group, Johnson & Johnson Services, Inc., Merck & Co. Inc., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi SA, Scilex Pharmaceuticals, Teva Pharmaceutical Industries Ltd., and Trevena Inc..

Market Segmentation & Coverage

This research report categorizes the Cancer Pain Management Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Drug Type
    • Nerve Blockers
    • Non-Opioids
      • Acetaminophen
      • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
    • Opioids
      • Fentanyl
      • Morphine
  • Route of Administration
    • Oral
    • Parental
  • Application
    • Blood Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Lung Cancer
    • Prostate Cancer
  • End-Use
    • Home care
    • Hospitals
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of chronic pain and lifestyle disorders worldwide
5.1.1.2. Increasing geriatric population and need for pain-reducing therapies
5.1.2. Restraints
5.1.2.1. Issues associated with product recalls
5.1.3. Opportunities
5.1.3.1. Ongoing product development activities and rising FDA approvals of new products
5.1.3.2. Government funding supporting cancer pain treatments
5.1.4. Challenges
5.1.4.1. Adverse effects associated with cancer pain management drugs
5.2. Market Segmentation Analysis
5.2.1. Drug Type: Growing applicability of opioids to treat cancer pain
5.2.2. Route of Administration: Growing availability of oral medications for cancer pain management
5.2.3. Application: Emerging penetration of cancer pain management solutions for breast cancer
5.2.4. End-Use: Elevating usage of cancer pain drugs in hospitals
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Cancer Pain Management Market, by Drug Type
6.1. Introduction
6.2. Nerve Blockers
6.3. Non-Opioids
6.3.1. Acetaminophen
6.3.2. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
6.4. Opioids
6.4.1. Fentanyl
6.4.2. Morphine
7. Cancer Pain Management Market, by Route of Administration
7.1. Introduction
7.2. Oral
7.3. Parental
8. Cancer Pain Management Market, by Application
8.1. Introduction
8.2. Blood Cancer
8.3. Breast Cancer
8.4. Colorectal Cancer
8.5. Lung Cancer
8.6. Prostate Cancer
9. Cancer Pain Management Market, by End-Use
9.1. Introduction
9.2. Home care
9.3. Hospitals
9.4. Specialty Clinics
10. Americas Cancer Pain Management Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Cancer Pain Management Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Cancer Pain Management Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. FDA Approves Non-Opioid Painkiller for Mild-to-Moderate Pain
13.3.2. Nevro's (NVRO) Latest Launch to Customize Chronic Pain Treatment
13.3.3. Esteve and Medtronic are Collaborating to Address Cancer Pain Patients’ Needs
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. CANCER PAIN MANAGEMENT MARKET RESEARCH PROCESS
FIGURE 2. CANCER PAIN MANAGEMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 13. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. CANCER PAIN MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. CANCER PAIN MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CANCER PAIN MANAGEMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CANCER PAIN MANAGEMENT MARKET DYNAMICS
TABLE 7. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY NERVE BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ACETAMINOPHEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY FENTANYL, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY MORPHINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY BLOOD CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 49. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 50. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 51. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 52. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 53. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 55. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 56. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 57. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 58. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 59. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 74. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 79. AUSTRALIA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. AUSTRALIA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 81. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 82. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 83. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 84. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 85. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 87. INDIA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 88. INDIA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 89. INDIA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 90. INDIA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 91. INDIA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. INDIA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 93. INDONESIA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 94. INDONESIA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 95. INDONESIA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 97. INDONESIA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. INDONESIA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 99. JAPAN CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 100. JAPAN CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 101. JAPAN CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 102. JAPAN CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 103. JAPAN CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. JAPAN CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 105. MALAYSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 106. MALAYSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 107. MALAYSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 109. MALAYSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. MALAYSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 111. PHILIPPINES CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 112. PHILIPPINES CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 113. PHILIPPINES CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 115. PHILIPPINES CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. PHILIPPINES CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 117. SINGAPORE CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 118. SINGAPORE CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 119. SINGAPORE CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 121. SINGAPORE CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. SINGAPORE CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 123. SOUTH KOREA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 124. SOUTH KOREA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 125. SOUTH KOREA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 127. SOUTH KOREA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. SOUTH KOREA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 129. TAIWAN CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 130. TAIWAN CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 131. TAIWAN CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 133. TAIWAN CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. TAIWAN CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 135. THAILAND CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 136. THAILAND CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 137. THAILAND CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 138. THAILAND CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 139. THAILAND CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. THAILAND CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 141. VIETNAM CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 142. VIETNAM CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 143. VIETNAM CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. VIETNAM CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 154. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 155. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 156. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 157. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 158. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 160. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 161. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 162. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 163. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 164. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 166. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 167. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 168. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 169. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 170. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 172. FRANCE CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 173. FRANCE CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 174. FRANCE CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 175. FRANCE CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 176. FRANCE CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. FRANCE CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 178. GERMANY CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 179. GERMANY CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 180. GERMANY CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 181. GERMANY CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 182. GERMANY CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. GERMANY CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 185. ISRAEL CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. ISRAEL CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 190. ITALY CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 191. ITALY CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 192. ITALY CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 193. ITALY CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 194. ITALY CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. ITALY CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 202. NIGERIA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 208. NORWAY CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 209. NORWAY CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 210. NORWAY CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 211. NORWAY CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 212. NORWAY CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. NORWAY CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 214. POLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 215. POLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 216. POLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 217. POLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 218. POLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. POLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 220. QATAR CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 221. QATAR CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 222. QATAR CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 223. QATAR CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 224. QATAR CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. QATAR CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 244. SPAIN CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 245. SPAIN CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 246. SPAIN CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 247. SPAIN CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 248. SPAIN CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. SPAIN CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 262. TURKEY CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 263. TURKEY CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 264. TURKEY CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 265. TURKEY CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 266. TURKEY CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 267. TURKEY CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 274. UNITED KINGDOM CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 280. CANCER PAIN MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 281. CANCER PAIN MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Cancer Pain Management Market, which are profiled in this report, include:
  • Abbott Laboratories
  • AbbVie Inc.
  • Aegis Therapeutics, LLC
  • Aptinyx Inc.
  • Astellas Pharma Inc.
  • Bausch Health Companies Inc.
  • Baxter International Inc.
  • Bayer AG
  • Biogen Inc.
  • Boehringer Ingelheim International GmbH
  • Eisai Co., Ltd.
  • Eli Lilly and Company
  • Glaxosmithkline PLC
  • Grünenthal Group
  • Johnson & Johnson Services, Inc.
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Regeneron Pharmaceuticals Inc.
  • Sanofi SA
  • Scilex Pharmaceuticals
  • Teva Pharmaceutical Industries Ltd.
  • Trevena Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages196
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 7.86 Billion
Forecasted Market Value ( USD ) by 2030 $ 11.23 Billion
Compound Annual Growth Rate6.0%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Pain Management Therapeutics Market by Therapeutics, Indication, Distribution Channel - Global Forecast 2025-2030 - Product Image

Pain Management Therapeutics Market by Therapeutics, Indication, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Cancer Pain Market Report and Forecast 2024-2032 - Product Image

Cancer Pain Market Report and Forecast 2024-2032

  • Report
  • 140 Pages
  • Global
From
Pain Management Drugs Global Market Report 2024 - Product Image

Pain Management Drugs Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Pain Management Drugs Market Report by Drug Class, Indication, Distribution Channel, and Region 2024-2032 - Product Image

Pain Management Drugs Market Report by Drug Class, Indication, Distribution Channel, and Region 2024-2032

  • Report
  • 141 Pages
  • Global
From
Advanced Cancer Pain Management - Pipeline Insight, 2024 - Product Image

Advanced Cancer Pain Management - Pipeline Insight, 2024

  • Drug Pipelines
  • 60 Pages
  • Global
From

About the Cancer Pain Management Market

The Cancer Pain Management market within the context of Palliative Care is focused on providing relief from the physical and psychological symptoms of cancer. This includes managing pain, fatigue, nausea, depression, anxiety, and other symptoms. Pain management strategies may include medications, physical therapy, psychological counseling, and other treatments. Palliative care also includes providing emotional and spiritual support to patients and their families. Companies in the Cancer Pain Management market include pharmaceutical companies, medical device manufacturers, and healthcare providers. Examples include Pfizer, Merck, Johnson & Johnson, Novartis, and AbbVie. Additionally, there are a number of specialized companies that focus on providing palliative care services, such as Hospice Care, Inc., and Comfort Care Hospice. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.